Physician profile
Daniel Brenner
NPI 1750561973
$15,599.58
in general payments reported to CMS, 2019-2025
29 companies · $5,765 in 2025
The $5,765 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,915 · 2020: $706 · 2021: $1,005 · 2022: $3,976 · 2023: $1,339 · 2024: $894 · 2025: $5,765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,595 · Travel and Lodging: $3,402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,595.22 |
| Travel and Lodging | $3,401.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,087.14 | 2021-2025 | Symplicity G3, Ffrangio, Micra |
| Abbott Laboratories | $1,616.66 | 2019-2025 | Cardiomems, Assurity, Amplatzer Amulet |
| Boston Scientific Corporation | $843.86 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, General - Tachy |
| Abiomed | $611.74 | 2019-2025 | Impella |
| Philips North America LLC | $567.28 | 2020-2025 | (P84) Igt Devices Systems, Mcot, (5044) Mcot |
| Boehringer Ingelheim Pharmaceuticals, INC. | $509.00 | 2021-2025 | Jardiance |
| Medtronic Vascular, INC. | $456.43 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $369.59 | 2019-2025 | Lifevest |
| Amgen INC. | $322.87 | 2019-2025 | |
| Inari Medical, INC. | $299.65 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Heartflow, INC. | $262.66 | 2020-2024 | Ffrct |
| Novartis Pharmaceuticals Corporation | $233.64 | 2019-2022 | |
| Edwards Lifesciences Corporation | $233.11 | 2020-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $225.18 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $142.47 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $124.63 | 2019-2020 | |
| Amarin Pharma, INC. | $113.40 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $106.50 | 2020-2023 | Farxiga |
| Terumo Medical Corporation | $102.55 | 2019-2024 | Azur Cx Detachable |
| Stryker Corporation | $78.16 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $53.71 | 2022 | |
| Pfizer INC. | $51.86 | 2025 | |
| Acist Medical Systems, INC. | $47.03 | 2019-2020 | |
| Esperion Therapeutics, INC. | $44.43 | 2023-2025 | Nexletol |
| Chiesi USA, INC. | $24.86 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $20.23 | 2019 | |
| Preventice Services, LLC | $18.55 | 2020 | |
| Sanofi-Aventis U.S. LLC | $18.22 | 2024 | |
| Irhythm Technologies, INC. | $14.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Brenner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.